Results 241 to 250 of about 433,567 (330)
Abstract Drug development for developmental and epileptic encephalopathies (DEEs) follows different strategies on one hand including disease‐targeting precision medicine approaches considering the genetic variants and pathomechanisms in DEEs and on the other hand including therapeutic approaches with novel targets or second‐generation drug candidates ...
Heidrun Potschka, Daniel Pérez‐Pérez
wiley +1 more source
Comparative analysis of autonomic effects of ketamine-xylazine in normotensive and hypertensive rats. [PDF]
Santos PS +14 more
europepmc +1 more source
Abstract Objective Central to the development of novel antiseizure medications (ASMs) is testing of antiseizure activity in preclinical models. Although various well‐established models exist, their predictive validity across the spectrum of clinical epilepsies has been less clear.
Lyndsey L. Anderson +9 more
wiley +1 more source
Dietary methionine depletion and hydrogen sulfide-producing genes in perivascular adipose tissue of male Wistar rats. [PDF]
Corken A +4 more
europepmc +1 more source
Abstract This study was undertaken to systematically evaluate the efficacy of cell therapy in reducing seizures in animal models of chronic epilepsy. Three databases, Ovid MEDLINE, Ovid Embase, and Web of Science, were searched using predetermined eligibility criteria.
Afaf S. Altalhi +6 more
wiley +1 more source
Hypoglycemic and Hypolipidemic Effects of <i>Leonotis mollisima</i> Aqueous Leaf Extract in Type 2 Diabetic Rats. [PDF]
Stephen N +4 more
europepmc +1 more source

